Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)

SHE:300683 Revenue

Wuhan Hiteck Biological Pharma Co.,Ltd had revenue of 159.05M CNY in the quarter ending March 31, 2026, with 1.52% growth. This brings the company's revenue in the last twelve months to 543.82M, down -19.28% year-over-year. In the year 2025, Wuhan Hiteck Biological Pharma Co.,Ltd had annual revenue of 541.45M, down -16.57%.

• Revenue (ttm): 543.82M
• Revenue Growth: -19.28%
• P/S Ratio: 8.48
• Revenue / Employee: 415.45K
• Employees: 1,309
• Market Cap: 4.61B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	541.45M	-107.52M	-16.57%
Dec 31, 2024	648.97M	46.69M	7.75%
Dec 31, 2023	602.28M	-86.34M	-12.54%
Jan 1, 2023	688.63M	73.94M	12.03%
Jan 1, 2022	614.68M	90.56M	17.28%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error